Thiazolidinediones such as rosiglitazone and pioglitazone, which are usually used in the treatment of type 2 diabetes, act as PPARγ agonists and stimulate the genes regulating insulin and fatty acid transcription, and restore the glycaemic profile in db/db mice. This evidence concerns the gene PPARG and type 2 diabetes mellitus.